Savior Lifetec (4167) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 松瑞藥

Savior Lifetec (4167) reported revenue of NT$136.2 million for Oct 2026, +21.3% year on year and +30.8% from the previous month. Revenue for Jan–Oct 2026 was NT$974.4 million (-2.0% year on year).

Year-on-year revenue growth: 3 months in a row. →

In Oct 2026, it ranked No. 59 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$103.7 million24/10Nov 2024 NT$115.3 millionDec 2024 NT$57.9 millionJan 2025 NT$97.8 millionFeb 2025 NT$72.2 million25/02Mar 2025 NT$93.9 millionApr 2025 NT$118.7 millionMay 2025 NT$114.3 millionJun 2025 NT$102.5 million25/06Jul 2025 NT$108.8 millionAug 2025 NT$95.8 millionSep 2025 NT$77.8 millionOct 2025 NT$112.3 million25/10Nov 2025 NT$87.9 millionDec 2025 NT$119.7 millionJan 2026 NT$83.9 millionFeb 2026 NT$64.4 million26/02Mar 2026 NT$85.4 millionApr 2026 NT$95.7 millionMay 2026 NT$88 millionJun 2026 NT$102.3 million26/06Jul 2026 NT$97.5 millionAug 2026 NT$117.2 millionSep 2026 NT$104.1 millionOct 2026 NT$136.2 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$136.2 million+21.3%+30.8%
Sep 2026NT$104.1 million+33.7%-11.2%
Aug 2026NT$117.2 million+22.3%+20.2%
Jul 2026NT$97.5 million-10.4%-4.7%
Jun 2026NT$102.3 million-0.2%+16.2%
May 2026NT$88 million-23.0%-8.1%
Apr 2026NT$95.7 million-19.4%+12.1%
Mar 2026NT$85.4 million-9.1%+32.6%
Feb 2026NT$64.4 million-10.9%-23.2%
Jan 2026NT$83.9 million-14.2%-30.0%
Dec 2025NT$119.7 million+106.7%+36.3%
Nov 2025NT$87.9 million-23.8%-21.7%
Oct 2025NT$112.3 million+8.2%+44.3%
Sep 2025NT$77.8 million-39.6%-18.8%
Aug 2025NT$95.8 million-12.1%-12.0%
Jul 2025NT$108.8 million+15.1%+6.2%
Jun 2025NT$102.5 million+13.7%-10.4%
May 2025NT$114.3 million-19.9%-3.7%
Apr 2025NT$118.7 million+2.5%+26.5%
Mar 2025NT$93.9 million+1.6%+30.0%
Feb 2025NT$72.2 million+33.5%-26.1%
Jan 2025NT$97.8 million-13.2%+68.8%
Dec 2024NT$57.9 million-46.1%-49.7%
Nov 2024NT$115.3 million+11.5%+11.1%
Oct 2024NT$103.7 million-3.2%-19.5%

Jan–Oct 2026 cumulative: NT$974.4 million (-2.0% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Savior Lifetec vs PEC / Savior Lifetec vs Lotus Pharm / Savior Lifetec vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16